BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22361915)

  • 1. Current treatment of peripheral T-cell lymphoma.
    Horwitz SM; Coiffier B; Hsi ED; Pro B
    Clin Adv Hematol Oncol; 2011 Aug; 9(8 Suppl 16):1-15. PubMed ID: 22361915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathological diagnosis of peripheral T-cell lymphoma and emerging treatment options: A case-based discussion.
    Said J; Pinter-Brown L
    Clin Adv Hematol Oncol; 2009 Nov; 7(11):S1, S4-13; quiz S15. PubMed ID: 20095101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of high-dose therapy in peripheral T-cell lymphomas.
    Reimer P; Rüdiger T; Wilhelm M
    Clin Lymphoma Myeloma; 2006 Mar; 6(5):373-9. PubMed ID: 16640812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
    Rogers AM; Brammer JE
    Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aggressive peripheral T-cell lymphomas: 2015.
    Armitage JO
    Am J Hematol; 2015 Jul; 90(7):665-73. PubMed ID: 26031230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral T-cell lymphoma: a case-based discussion of recent advances in patient management.
    Franco CM; Popplewell LL; Horwitz SM
    Clin Adv Hematol Oncol; 2011 Apr; 9(4 Suppl 9):1-16. PubMed ID: 21559001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral T-cell lymphoma--not otherwise specified.
    Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.
    Blystad AK; Enblad G; Kvaløy S; Berglund A; Delabie J; Holte H; Carlson K; Kvalheim G; Bengtsson M; Hagberg H
    Bone Marrow Transplant; 2001 Apr; 27(7):711-6. PubMed ID: 11360110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose therapy and stem cell transplantation.
    Zinzani PL
    Semin Hematol; 2010 Apr; 47 Suppl 1():S15-7. PubMed ID: 20359581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation in the treatment of peripheral T-cell lymphomas.
    Majhail NS; Burns LJ
    Curr Hematol Rep; 2005 Jul; 4(4):252-9. PubMed ID: 16009039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
    d'Amore F; Relander T; Lauritzsen GF; Jantunen E; Hagberg H; Anderson H; Holte H; Österborg A; Merup M; Brown P; Kuittinen O; Erlanson M; Østenstad B; Fagerli UM; Gadeberg OV; Sundström C; Delabie J; Ralfkiaer E; Vornanen M; Toldbod HE
    J Clin Oncol; 2012 Sep; 30(25):3093-9. PubMed ID: 22851556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current state of art for transplantation paradigms in peripheral T-cell lymphomas.
    Perrone G; Farina L; Corradini P
    Expert Rev Hematol; 2013 Aug; 6(4):465-74. PubMed ID: 23991932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
    Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
    Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets.
    Rodríguez J; Gutiérrez A; Martínez-Delgado B; Perez-Manga G
    Crit Rev Oncol Hematol; 2009 Sep; 71(3):181-98. PubMed ID: 19056295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review.
    Rodriguez-Abreu D; Filho VB; Zucca E
    Hematol Oncol; 2008 Mar; 26(1):8-20. PubMed ID: 18050364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Peripheral T-Cell Lymphoma: Many Shades of Gray.
    Lunning MA
    Oncology (Williston Park); 2015 Aug; 29(8):545-50. PubMed ID: 26281838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral T-cell lymphoma: autologous hematopoietic cell transplantation as first-line therapy.
    Laport GG
    Curr Opin Oncol; 2010 Sep; 22(5):409-13. PubMed ID: 20683269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral T-cell lymphoma: new therapeutic strategies.
    Petrich AM; Rosen ST
    Oncology (Williston Park); 2013 Sep; 27(9):878-84. PubMed ID: 24282984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation.
    Zain J
    Cancer Treat Res; 2019; 176():269-287. PubMed ID: 30596223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.